Demonstration of different modes of cell death upon herpes simplex virus 1 infection in different types of oral cells

Acta Virologica

Volumn 49, Issue 1, 2005, Pages 7-15

  Huang, C R ^a   Lin, S S ^a   Chou, M Y ^a,b   Ho, C C ^a,b   Wang, L ^b   Lee, Y L ^b   Chen, C S ^b,c   Yang, C C ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c KUANG TIEN GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; DNA fragmentation; Necrosis; Phosphatidylserine; Slow cell death

Indexed keywords

CASPASE 3; DNA FRAGMENT; LIPOCORTIN 5; VIRUS ANTIGEN; CASP3 PROTEIN, HUMAN; CASPASE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; CHEEK MUCOSA; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME ACTIVITY; FIBROBLAST; GINGIVA DISEASE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MOUTH CANCER; NECK METASTASIS; PROTEIN BINDING; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; CELL CULTURE; CELL STRAIN KB; CELL SURVIVAL; CYTOLOGY; GINGIVA; GINGIVA TUMOR; METABOLISM; MOUTH; MOUTH DISEASE; MOUTH MUCOSA; MOUTH TUMOR; NECROSIS; PATHOLOGY; PHYSIOLOGY; TONGUE TUMOR; VIROLOGY;

HUMAN HERPESVIRUS 1;

ANNEXIN A5; ANTIGENS, VIRAL; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CASPASES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CYTOPATHOGENIC EFFECT, VIRAL; DNA FRAGMENTATION; FIBROBLASTS; GINGIVA; GINGIVAL NEOPLASMS; HERPESVIRUS 1, HUMAN; HUMANS; KB CELLS; MOUTH; MOUTH MUCOSA; MOUTH NEOPLASMS; NECROSIS; ORAL SUBMUCOUS FIBROSIS; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 23844553975     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Amarante-Mendes GP, Finucane DM, Martin SJ, Cotter TG, Salvesen GS, Green DR (1998): Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. 5, 298-306.
2. Aubert M, Rice SA, Blaho JA (2001): Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells. J. Virol. 75, 1013-1030.
3. Blagosklonny (2000): Cell death beyond apoptosis. Leukemia 14, 1502-1508.
4. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H (1984): A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3, 1151-1157.
5. Chang BD, Xuan T, Broude EV, Zhu H, Schott B, Fang J, Roninson IB (1999): Role of p53 and p21 waf1/cip1 in senescence-like terminal proliferation arrest induced in human cells by chemotherapeutic drugs. Oncogene 18, 4808-4818.
6. Chautan M, Chazal G, Cecconi F, Gruss P, Golstein P (1999): Intergigital cell death can occur through a necrotic and caspase-independent pathway. Curr. Biol. 9, 967-970.
7. Chen MC, Hwang MJ, Chou YC, Chen WH, Cheng G, Nakano H, Luh TY, Mai SC, Hsieh SL (2003): The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death. J. Biol. Chem. 278, 16073-16081.
8. Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA (1997): Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cystein protease. Am. J. Pathol. 151, 1205-1213.
9. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998): A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50.
10. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998): Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAR J. Clin. Invest. 101, 890-898.
11. Fletcher RD, Guggenheimer J, Sumney D, Platt D (1975): Herpes simplex virus type 1 replication in a gingival cell line. J. Dent. Res. 54, 441-443.
12. Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE, Capaccioli S, Orlandini SZ (2000): Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J. Cell Physiol. 182, 41-49.
13. Geske FJ, Lieberman R, Strange R, Gerschenson LE (2001): Early stages of p53-induced apoptosis are reversible. Cell Death Differ. 8, 182-191.
14. Hong JR, Lin TL, Hsu YL, Wu JL (1998): Apoptosis precedes necrosis of fish cell line with infectious pancreatic necrosis virus infection. Virology 250, 76-84.
15. Houghton JA (1999): Apoptosis and drug response. Curr. Opin. Oncol. 11, 475-481.
16. Hung SL, Wang YH, Chen HW, Lee PL, Chen YT (2002): Analysis of herpes simplex virus entering into cells of oral origin. Virus Res. 86, 59-69.
17. Janicke RU, Sprengart ML, Wait MR, Porter AG (1998): Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360.
18. Khodarev NN, Sokolova IA, Vaughan AT (1998): Mechanisms of induction of apoptotic DNA fragmentation. Int. J. Radiat. Biol. 73, 455-467.
19. Kitanaka C, Kuchino Y (1999): Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 6, 508-515.
20. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC (1994): Cleavage of poly(ADP-ribose)polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
21. Lee YJ, Liao PH, Chen WK, Yang CC (2000). Preferential cytotoxicity of caffeic acid phenythyl ester analogues on oral cancer cells. Cancer Lett. 153, 51-56.
22. Lemasters JJ (1999): V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am. J. Physiol. 276, G1-6.
23. Leopardi R, Sant CV, Roizman B (1997): The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc. Natl. Acad. Sci. USA 94, 7891-7896.
24. Lin SS, Chou MY, Ho CC, Kao CT, Wang L, Yang CC (2004): Study of the viral infections and cytokines associated with recurrent aphthous ulceration. Microbes Infect. (in press).
25. Martin SI, Finucance DM, Amarante-Mendes GP, O'Brien GA, Green DR (1996): Phosphatidylserine externalization during CD95-induccd apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271, 28753-28756.
26. Mcllroy D, Sakahira H, Talanian RV, Nagata S (1999): Involvment of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli. Oncogene 18, 4401-4408.
27. Mills JC, Stone NL, Pittman RN (1999): Extranuclear apoptosis: the role of the cytoplasm in the execution phase. J. Cell Biol. 146, 703-707.
28. Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
29. Munger J, Roizman B (2001): The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents B AD-induced programmed cell death in the absence of other viral proteins. Proc. Natl. Acad. Sci. USA 98, 10410-10415.
30. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M (1993): Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12, 3679-3684.
31. O'Brien V (1998): Viruses and apoptosis. J. Gen. Virol. 79, 1833-1845.
32. Ormerod MG, Oneill CF, Robertson D, Harrap KR (1994): Cisplatin induces apoptosis in a human ovarian-carcinoma cell-line without concomitant internucleaosomal degradation of DNA. Exp. Cell Res. 211, 231-237.
33. Polverini PJ, Nor JE (1999): Apoptosis and predisposition to oral cancer. Crit. Rev. Oral Biol. Med. 10, 139-152.
34. Rasola A, Farahi FD, Hofman P, Rossi B (1999): Lack of internucleosomal DNA fragmentation is related to Cl(-) efflux impairment in hematopoitic cell apoptosis. FASEB J. 13, 1711-1723.
35. Ravi DK, Ramadas BS, Mathew KR, Nalinakumari M, Nair K, Pillai MR (1999): De novo programmed cell death in oral cancer. Histopathology 34, 241-249.
36. Roulston A, Marcellus RC, Branton PE (1999): Viruses and apoptosis. Annu. Rev. Microbiol. 53, 577-628.
37. Shillitoe EJ, Gilchrist E, Pellenz C, Murrah V (1999): Effects of herpes simplex virus on human oral cancer cells, and potential use of mutant viruses in therapy of oral cancer. Oral Oncol. 35, 326-332.
38. Shimizu S, Eguchi Y, Kamiike W, Itoh Y, Hasegawa J-I, Yamabe K, Ohtsuki Y, Matsuda H, Tsujimoto Y (1996a): Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by bcl-2 and bcl-xL. Cancer Res. 56, 2161-2166.
39. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsujimoto Y (1996b): Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 12, 2251-2257.
40. Spear PG, Eisenberg RJ, Cohen GH (2000): Three classes of cell surface receptors for alphaherpesvirus entry. Virology 275, 1-8.
41. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S (1995): Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147.
42. Takizawa T, Tatematsu C, Nakanishi Y (2002): Double-stranded RNA-activated protein kinase interacts with apoptosis signal-regulating kinase 1. Implications for apoptosis signaling pathways, fur. J. Biochem. 269, 6126-6132.
43. Thomson BI (2001): Viruses and apoptosis. Int. J. Exp. Pathol. 82, 65-76.
44. Vermes I, Haanen C, Steffeus-Nakken H, Reutellingsperger C (1995): A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184, 39-51.
45. Yang YY, Koh LW, Tsai JH, Tsai CH, Wong EFC, Lin SJ, Yang CC (2004): Involvement of viral and chemical factors with oral cancer in Taiwan. Jpn. J. Clin. Oncol. 34, 176-183.
46. Zeuner A, Eramo A, Peschle C, De Maria R (1999): Caspase activation without death. Cell Death Differ. 6, 1075-1080.